…
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It offers YelloPort Elite port access systems; YelloPort + Resposable port access systems; LogiCut, a disposable laparoscopic scissors; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. The company also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and building of instruments. In addition, it distributes specialist medical products; and designs and manufactures autologous blood products. The company sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -2.05M | -0.73M | -0.06M | -0.58M | -3.31M |
| Net income | -1.94M | -0.51M | 0.26M | -0.46M | -3.28M |
| Selling general administrative | 1.14M | 0.87M | 0.74M | 0.80M | 0.79M |
| Selling and marketing expenses | 1.57M | 1.76M | 1.67M | 1.33M | 1.22M |
| Gross profit | 3.44M | 3.45M | 3.92M | 3.13M | 1.27M |
| Reconciled depreciation | 1.85M | 0.76M | 0.59M | 0.85M | 2.29M |
| Ebit | -1.95M | -0.60M | 0.04M | -0.48M | -3.79M |
| Ebitda | -0.10M | 0.16M | 0.63M | 0.37M | -1.50M |
| Depreciation and amortization | 1.85M | 0.76M | 0.59M | 0.85M | 2.29M |
| Operating income | -0.79M | -0.60M | 0.04M | -0.48M | -3.79M |
| Other operating expenses | 12.74M | 12.61M | 11.30M | 9.61M | 10.12M |
| Interest expense | 0.10M | 0.13M | 0.10M | 0.13M | 0.14M |
| Tax provision | -0.11M | -0.22M | -0.32M | -0.13M | -0.03M |
| Interest income | - | - | 0.00M | 0.00M | 0.00M |
| Net interest income | -0.10M | -0.13M | -0.10M | -0.13M | -0.14M |
| Income tax expense | -0.11M | -0.22M | -0.32M | -0.13M | -0.03M |
| Total revenue | 11.95M | 12.01M | 11.34M | 9.13M | 6.33M |
| Total operating expenses | 4.23M | 4.04M | 3.88M | 3.61M | 5.06M |
| Cost of revenue | 8.51M | 8.57M | 7.42M | 6.00M | 5.06M |
| Total other income expense net | -1.26M | -0.13M | -0.10M | -0.10M | 0.48M |
| Net income from continuing ops | -1.94M | -0.51M | 0.26M | -0.46M | -3.28M |
| Net income applicable to common shares | - | - | 0.26M | -0.46M | -3.28M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 12.24M | 14.32M | 15.60M | 15.72M | 16.34M |
| Intangible assets | - | 1.11M | 0.98M | 0.79M | 0.75M |
| Other current assets | 0.29M | 0.43M | - | 1.70M | 1.28M |
| Total liab | 3.70M | 3.84M | 4.63M | 5.05M | 5.25M |
| Total stockholder equity | 8.54M | 10.48M | 10.96M | 10.66M | 11.09M |
| Deferred long term liab | - | - | 0.98M | 0.79M | 0.75M |
| Other current liab | 0.96M | 0.62M | 0.89M | 1.01M | 0.24M |
| Common stock | 9.33M | 9.33M | 9.33M | 9.33M | 9.33M |
| Capital stock | 9.33M | 9.33M | 9.33M | 9.33M | 9.33M |
| Retained earnings | -8.95M | -7.01M | -6.53M | -6.83M | -6.40M |
| Other liab | - | - | - | 0.17M | 0.17M |
| Good will | 5.42M | 5.42M | 5.42M | 5.42M | 5.42M |
| Other assets | - | - | 0.98M | 0.79M | 0.75M |
| Cash | 0.20M | 1.21M | 2.20M | 3.64M | 5.28M |
| Total current liabilities | 2.83M | 2.62M | 2.92M | 4.14M | 2.30M |
| Current deferred revenue | - | - | - | - | 0.83M |
| Net debt | 1.04M | 0.45M | -0.04M | -0.86M | -2.01M |
| Short term debt | 0.54M | 0.61M | 0.61M | 2.04M | 0.48M |
| Short long term debt | 0.35M | 0.35M | 0.38M | 1.88M | 0.30M |
| Short long term debt total | 1.24M | 1.66M | 2.16M | 2.79M | 3.27M |
| Other stockholder equity | 8.17M | 8.17M | 8.17M | 8.17M | 8.17M |
| Property plant equipment | - | - | - | 1.20M | 1.44M |
| Total current assets | 5.32M | 6.09M | 7.42M | 8.30M | 8.73M |
| Net tangible assets | - | - | 5.54M | 5.24M | 5.67M |
| Net receivables | 1.87M | 1.59M | 2.06M | 1.70M | 0.99M |
| Long term debt | 0.15M | 0.50M | 0.82M | 0.00M | 1.88M |
| Inventory | 2.97M | 2.85M | 3.16M | 2.96M | 2.17M |
| Accounts payable | 1.14M | 1.17M | 1.42M | 1.09M | 0.75M |
| Accumulated other comprehensive income | - | 0.33M | - | - | - |
| Common stock total equity | - | - | - | - | 9.33M |
| Non currrent assets other | - | 1.11M | - | - | - |
| Non current assets total | 6.92M | 8.23M | 8.18M | 7.41M | 7.62M |
| Capital lease obligations | 0.74M | 0.81M | 0.95M | 0.91M | 1.09M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | -0.34M | -0.69M | -1.08M | -0.66M | -0.15M |
| Change to liabilities | - | - | 0.00M | 0.28M | -0.01M |
| Total cashflows from investing activities | -0.34M | -0.69M | -1.08M | -0.66M | -0.15M |
| Net borrowings | -0.35M | -0.35M | -0.94M | -0.53M | 1.10M |
| Total cash from financing activities | -0.63M | -0.67M | -0.94M | -0.53M | 3.15M |
| Net income | -1.94M | -0.51M | 0.26M | -0.46M | -3.28M |
| Change in cash | -1.02M | -0.99M | -1.45M | -1.63M | 4.00M |
| Begin period cash flow | 1.21M | 2.20M | 3.64M | 5.28M | 1.28M |
| End period cash flow | 0.20M | 1.21M | 2.20M | 3.64M | 5.28M |
| Total cash from operating activities | -0.07M | 0.40M | 0.49M | -0.43M | 1.04M |
| Issuance of capital stock | - | - | - | 0.00M | 2.05M |
| Depreciation | 1.85M | 0.76M | 0.59M | 0.85M | 2.29M |
| Other cashflows from investing activities | -0.27M | -0.40M | - | - | - |
| Change to inventory | -0.12M | 0.31M | -0.20M | -0.80M | 0.76M |
| Change to account receivables | -0.13M | 0.03M | -0.36M | -0.41M | 1.08M |
| Other cashflows from financing activities | -0.27M | -0.32M | -0.27M | -0.23M | 1.25M |
| Change to netincome | - | - | -0.01M | 0.11M | 1.34M |
| Capital expenditures | 0.34M | 0.69M | 1.08M | 0.66M | 0.15M |
| Change in working capital | 0.04M | 0.04M | -0.35M | -0.94M | 1.82M |
| Stock based compensation | 0.00M | 0.03M | 0.04M | 0.03M | 0.12M |
| Other non cash items | -0.02M | 0.08M | -0.05M | 0.11M | 0.11M |
| Free cash flow | -0.41M | -0.29M | -0.59M | -1.09M | 0.89M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SUN Surgical Innovations Group plc |
- -% |
0.40 | - | - | 0.35 | 0.49 | 0.47 | 16.22 |
| SN Smith & Nephew PLC |
-14.00 1.23% |
1122.50 | 23.24 | 12.47 | 1.70 | 2.59 | 2.67 | 10.76 |
| NIOX NIOX Group PLC |
2.00 2.99% |
69.00 | 28.20 | 18.73 | 4.84 | 3.41 | 4.35 | 13.85 |
| EKF EKF Diagnostics Holdings Plc |
-0.40 1.61% |
24.40 | - | 34.97 | 2.02 | 1.46 | 1.72 | 7.01 |
| CREO Creo Medical Group PLC |
- -% |
11.25 | - | - | 199.36 | 0.74 | 6.21 | 8.16 |
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It offers YelloPort Elite port access systems; YelloPort + Resposable port access systems; LogiCut, a disposable laparoscopic scissors; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. The company also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and building of instruments. In addition, it distributes specialist medical products; and designs and manufactures autologous blood products. The company sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Matthew R. Potere | CEO & Director | 1975 |
| Mr. Timothy Parsons | Exec. VP & COO | 1978 |
| Mr. Barry Edinburg | Advisor | 1969 |
| Mr. Rodney Yoder | Exec. VP & CFO | 1968 |
| Mr. Scott Mulloy | Exec. VP & Chief Information Officer | 1972 |
| Mr. Yoni Cohen | Head of Bus. Devel. & Marketing | NA |
| Ms. Marnie Woodward P.H.R. | Head of HR | NA |
| Mr. Kevin Jurczyk | Head of Home Improvement Sales | NA |
| Mr. David John Marsh | CEO & Director | 1964 |
| Mr. Brent Raymond Greetham | CFO, Company Secretary & Director | 1976 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.